Moreover, quantitative comparison by multiplex analysis (i.e., iTRAQ) of the proteome signatures induced by quercetin among other CML cells expressing the fusion gene BCR-ABL1 will help in highlighting the quercetin effects at its pivotal biological processes. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.